Advanced Course on Immunity and Cancer Immunotherapy 2024

The Immunity and Cancer Unit of Institut Curie (INSERM U932) is organizing the 7th edition of the Advanced Course on Immunity and Cancer Immunotherapy.

In the context of ongoing cooperation projects with research teams in Chile and Argentina that have resulted in the prior organization of workshops in cell biology and immunology, this year’s edition is jointly organized with the Fundación Ciencia & Vida (Chile) and will be dedicated to multiple aspects of fundamental immunology and possible applications in cancer immunotherapy. The course will offer 4 days of lectures and discussions centered on the latest developments in innate immunity, myeloid and lymphoid cell biology, tissue immunity and the role of the microenvironment in immune activation, cancer immunity, as well as state-of-the-art cell therapy and cancer immunotherapy. Besides attending the lectures, the participants will have the opportunity to present their projects during two poster sessions, discuss with the speakers, attend workshops on open science and scientific integrity, and participate in a round table on career opportunities.

Expanding the links with Latin American research institutions, the Advanced course on Immunity and Cancer Immunotherapy is jointly organized with the 3rd Franco-Austral Course on Bioinformatics Applied to Immunology, taking place in Buenos Aires, Argentina, from October 30th to November 2nd, just before the 2024 meeting of the Latin American and Caribbean Association for Immunology.

The Advanced Course on Immunity and Cancer Immunotherapy is exclusively destined to Master students, PhD students and postdoctoral researchers from Latin American universities and/or research institutions.

The course is organized and funded by the LabEx DCBIOL, Institut Curie’s Advanced Training Office, Institut Curie’s Medico-Scientific Program in Immunotherapy, the Inserm CIC-1428, PSL University, Universidad San Sebastián, Centro BASAL Ciencia & Vida (ANID-FB210008) and Fundación Ciencia & Vida. The cell therapy session is organized and funded by the RHU EpCART, a structuring project funded by the French National Research Agency (ANR) in the framework of the France 2030 program.

Course organizers:

Ana-Maria Lennon-Duménil (Insititut Curie, FR)

Eliane Piaggio (Institut Curie, FR)

María Soledad Matus (USS-Fundación Ciencia & Vida, CL)

Mario Rosemblatt (USS-Fundación Ciencia & Vida, CL)

Álvaro Lladser (USS-Fundación Ciencia & Vida, CL)

Mariana Maccioni (National University of Córdoba, CIBICI-CCT-CONICET, AR)

Nathalie Amzallag (Institut Curie, FR)

Inês Pires Pinheiro (Institut Curie, FR)